Advanced company searchLink opens in new window

TAKEDA CAMBRIDGE LIMITED

Company number 03585995

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
26 Jun 2023 CS01 Confirmation statement made on 23 June 2023 with no updates
08 Apr 2023 AA Full accounts made up to 31 March 2022
15 Dec 2022 AP01 Appointment of Mr Peter Michael Grubin as a director on 13 December 2022
12 Sep 2022 TM01 Termination of appointment of Charmaine Linda Reid as a director on 31 August 2022
27 Jun 2022 CS01 Confirmation statement made on 23 June 2022 with no updates
06 Apr 2022 AA Full accounts made up to 31 March 2021
08 Jul 2021 TM01 Termination of appointment of David Isaacs as a director on 30 June 2021
23 Jun 2021 CS01 Confirmation statement made on 23 June 2021 with no updates
28 Apr 2021 AP01 Appointment of Mr Marc Stuart Page as a director on 28 April 2021
26 Mar 2021 AA Full accounts made up to 31 March 2020
01 Oct 2020 AP01 Appointment of Mrs Charmaine Linda Reid as a director on 29 September 2020
29 Sep 2020 TM01 Termination of appointment of Mark Conrad Fowler as a director on 25 September 2020
23 Jun 2020 CS01 Confirmation statement made on 23 June 2020 with no updates
23 Dec 2019 AA Full accounts made up to 31 March 2019
24 Jun 2019 CS01 Confirmation statement made on 23 June 2019 with updates
14 Jan 2019 SH20 Statement by Directors
14 Jan 2019 SH19 Statement of capital on 14 January 2019
  • GBP 0.10
14 Jan 2019 CAP-SS Solvency Statement dated 14/01/19
14 Jan 2019 RESOLUTIONS Resolutions
  • RES13 ‐ Cancellation of share premium account and capital redemption reserve 14/01/2019
  • RES06 ‐ Resolution of reduction in issued share capital
27 Dec 2018 AA Full accounts made up to 31 March 2018
27 Jun 2018 CS01 Confirmation statement made on 23 June 2018 with no updates
04 Jan 2018 AP01 Appointment of Mr Andrew Raymond Spicer as a director on 19 December 2017
21 Dec 2017 AA Full accounts made up to 31 March 2017
28 Jun 2017 CS01 Confirmation statement made on 23 June 2017 with updates
28 Jun 2017 PSC02 Notification of Takeda Pharmaceutical Company Limited as a person with significant control on 6 April 2016